Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 27 April, 2020

JP Morgan Sec LLC

AbbVie Inc. 38.5(b)

RNS Number : 9717K
J.P. Morgan Securities LLC
27 April 2020
 

Ap27

 

 

FORM   38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, 
OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

J.P Morgan Securities LLC

Companydealtin

AbbVie Inc.

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

Common stock

Date of dealing

24 April 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   2)

 

 

Long

Short

 

Number

 

(%)

Number

 

(%)

 11,700,268  0.79

 4,387,153  0.30

(2) Derivatives (other than options)

 3,446,077  0.23

 1,958,015  0.13

(3)Optionsandagreementstopurchase/sell

 751,400  0.05

 777,000  0.05

Total

 15,897,745  1.07

 7,122,168  0.48

             

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   2)

 

Classofrelevantsecurity:

Long

Short

 

Number

 

(%)

Number

 

(%)

 

 

(2) Derivatives (other than options)

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

 

 

             

 

Ap28

 

 

3.  DEALINGS  (Note   3)

 

(a)  Purchases and sales

 

Purchase/sale

Numberofrelevantsecurities

Priceperunit (Note 4)

Purchase (New Borrow)

 

Purchases

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

266,700

 

75,724

25

8

8

147

14,357

64

75,724

200

143

200

51

103

205

210

123

251

53

122

276

51

151

143

120

51

385

200

114

173

336

154

259

3,686

7,978

64

12,859

50

7,977

54

231

563

165

115

100

450

20

100

51

50

1

50

50

534

500

1,091

300

400

51

100

113

150

10,263

100

 

37,862

1

3

1

1

1

7

7

4

30

24

1

2

1,918

8

2,952

2,078

500

101

2

14,357

3

75,724

2,870

558

100

200

4

1,530

1,751

4

2

2

1

3

5

2

24

1

1

6

1

2

1

4

2

6

1

19

1

1

1

100

200

1

1

400

3

66

100

1

200

434

100

1,226

200

200

400

100

200

191

63,507

NA

 

82.7714 USD

82.8357 USD

82.9600 USD

82.9625 USD

82.9806 USD

83.0156 USD

83.0200 USD

83.0392 USD

83.0400 USD

83.0500 USD

83.0511 USD

83.0700 USD

83.0800 USD

83.1000 USD

83.1100 USD

83.1176 USD

83.1200 USD

83.1204 USD

83.1300 USD

83.1400 USD

83.1600 USD

83.1700 USD

83.1722 USD

83.1744 USD

83.1800 USD

83.1854 USD

83.1900 USD

83.2000 USD

83.2100 USD

83.2200 USD

83.2300 USD

83.2400 USD

83.2438 USD

83.2439 USD

83.2500 USD

83.2503 USD

83.2600 USD

83.2644 USD

83.2700 USD

83.2800 USD

83.2834 USD

83.2900 USD

83.3000 USD

83.3200 USD

83.3300 USD

83.3310 USD

83.3400 USD

83.3600 USD

83.3700 USD

83.3800 USD

83.3904 USD

83.4200 USD

83.4340 USD

83.4449 USD

83.4475 USD

83.4500 USD

83.4525 USD

83.4900 USD

83.5200 USD

83.5300 USD

83.5518 USD

83.5900 USD

83.6000 USD

 

82.7714 USD

82.8100 USD

82.8433 USD

82.8500 USD

82.8600 USD

82.8700 USD

82.8814 USD

82.8929 USD

82.9175 USD

82.9207 USD

82.9283 USD

82.9400 USD

82.9500 USD

82.9618 USD

82.9625 USD

82.9817 USD

82.9910 USD

82.9980 USD

83.0000 USD

83.0100 USD

83.0156 USD

83.0167 USD

83.0392 USD

83.0425 USD

83.0495 USD

83.0500 USD

83.0511 USD

83.0600 USD

83.0709 USD

83.0733 USD

83.0875 USD

83.0900 USD

83.0950 USD

83.1100 USD

83.1467 USD

83.1500 USD

83.1600 USD

83.1663 USD

83.1700 USD

83.1800 USD

83.1883 USD

83.1900 USD

83.2000 USD

83.2100 USD

83.2175 USD

83.2400 USD

83.2433 USD

83.2500 USD

83.2679 USD

83.2700 USD

83.2800 USD

83.3200 USD

83.3300 USD

83.3386 USD

83.3400 USD

83.3500 USD

83.3674 USD

83.3800 USD

83.3918 USD

83.3919 USD

83.4100 USD

83.4170 USD

83.4425 USD

83.4500 USD

83.4745 USD

83.4800 USD

83.5150 USD

83.5396 USD

83.5400 USD

83.5416 USD

83.5476 USD

83.5900 USD

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 5)

Numberofrelevantsecurities

(Note 6)

Priceperunit

(USD)

(Note 4)

Equity Swaps

Long

 

 

Short

14,357

33

 

8

75,724

200

83.0156

83.5900

 

82.9625

83.0392

83.0511

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 4)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 4)

 

 

 

 

 

(d)  Other   dealings   (including   transactions   in   respect   of   new   securities)   (Note   3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

Ap29

 

4.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any   other   person   relating   to   the   voting   rights   of   any   relevant   securities   under   any   option   referred   to  

on   this   form   or   relating   to   the   voting   rights  or future acquisition or disposal of any relevant securities 

to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached?  (Note   8)    YES

 

 

Dateofdisclosure

27 April 2020

Contactname

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

Allergan plc

Nature of connection (Note 9)

Financial Advisor to Allergan plc

 

 

Ap31

 

 

SUPPLEMENTAL   FORM   38.5(b)

 

 

 

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   38.5(b))   OPEN POSITIONS  (Note   1)

 

Productname,

e.g. call option

Written orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2)

Type, e.g.American,Europeanetc.

Expiry date

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Call Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Put Option

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Purchased

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

Written

10,000

6,100

41,200

8,400

11,200

7,200

21,100

2,500

7,900

5,600

2,500

8,500

10,000

100,000

50,000

15,000

15,000

20,000

7,900

9,500

8,500

6,100

18,200

8,400

11,200

7,200

21,100

2,500

4,500

5,600

2,500

20,000

15,000

15,000

20,000

102,500

31,300

32,300

16,400

84,000

900

7,000

4,400

45,000

29,100

9,700

4,900

12,100

12,100

800

140,000

5,100

3,000

600

20,000

15,000

15,000

20,000

102,500

31,300

32,300

11,400

8,900

1,900

4,400

29,100

20,000

100,000

15,000

15,000

20,000

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

105.00

110.00

70.00

92.50

91.57

95.93

82.37

95.00

100.00

105.00

110.00

85.00

92.50

95.00

100.00

80.00

87.50

90.00

97.50

115.00

82.50

91.57

95.93

82.37

60.00

65.00

70.00

75.00

77.50

85.00

72.50

67.50

80.00

55.00

60.00

65.00

70.00

75.00

77.50

82.50

62.50

72.50

67.50

80.00

78.49

82.85

78.35

60.00

65.00

70.00

75.00

77.50

72.50

67.50

55.00

60.00

70.00

78.49

82.85

78.35

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

American

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

18SEP20

18SEP20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

19JUN20

15JAN21

15JAN21

15JAN21

15JAN21

15JAN21

 

 

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rules 8 and

38.5 of the Rules. If in doubt, consult the Panel.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBGGDSRBDDGGR

a d v e r t i s e m e n t